MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$15,359K
EPS
-$0.31
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
12,611
11,707
11,468*
11,915
General and administrative
4,288
3,908
3,745*
3,586
Total operating expenses
16,899
15,615
15,212
15,501
Loss from operations
-16,899
-15,615
-15,212*
-15,501
Interest income
1,553
458
831*
804
Interest and other expense
-
-
2*
2
Total other income
1,553
458
829*
802
Net loss
-15,346
-15,157
-14,383
-14,699
Unrealized loss on available-for-sale securities, net
-13
-
-
-
Total comprehensive loss
-15,359
-
-
-
Basic EPS
-0.31
-1.11
-1.065
-1.09
Diluted EPS
-0.31
-1.11
-1.065
-1.09
Basic Average Shares
49,869,177
13,674,577
13,507,773
13,530,892
Diluted Average Shares
49,869,177
13,674,577
13,507,773
13,530,892
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
loss
-$15,359K
Interest income
$1,553K
(66.27%↑ Y/Y)
Net loss
-$15,346K
(0.29%↑ Y/Y)
Unrealized loss on
available-for-sale securities, net
-$13K
Total other income
$1,553K
(66.27%↑ Y/Y)
Loss from operations
-$16,899K
(-3.52%↓ Y/Y)
Total operating
expenses
$16,899K
(3.52%↑ Y/Y)
Research and development
$12,611K
(-0.02%↓ Y/Y)
General and
administrative
$4,288K
(15.55%↑ Y/Y)
Buy us a coffee
OnKure Therapeutics, Inc. (OKUR)
OnKure Therapeutics, Inc. (OKUR)